Literature DB >> 7200032

Prognostic significance of CEA in breast cancer: a statistical study.

M De Jong-Bakker, A A Hart, J P Persijn, F J Cleton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7200032     DOI: 10.1016/0014-2964(81)90013-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  7 in total

1.  Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.

Authors:  J C van der Linden; J P Baak; T Postma; J Lindeman; C J Meyer
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

2.  Markers in breast cancer: does CEA add to the detection by CA 15.3?

Authors:  J C Delarue; H Mouriesse; F Dubois; S Friedman; F May-Levin
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

3.  Prospective assessment of the role of five tumour markers in breast cancer.

Authors:  J F Robertson; D Pearson; M R Price; C Selby; J Pearson; R W Blamey; A Howell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  Circulating tumour markers in breast cancer.

Authors:  Ettore Seregni; Antonio Coli; Nicola Mazzucca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-04       Impact factor: 9.236

5.  Analysis of cytosol CA15-3, carcinoembryonic antigen, estrogen and progesterone receptors in breast cancer tissues.

Authors:  T Miya; T Watanabe; I Adachi; M Itabashi; T Fukutomi; K Yamaguchi; K Abe; M Arakawa
Journal:  Jpn J Cancer Res       Date:  1992-02

Review 6.  Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

Authors:  Xuan Li; Danian Dai; Bo Chen; Hailin Tang; Xiaoming Xie; Weidong Wei
Journal:  Dis Markers       Date:  2018-05-02       Impact factor: 3.434

7.  Double antibody radioimmunoassay for monitoring metastatic breast cancer.

Authors:  R L Schecter; P P Major; P E Kovac; M Ishida; E C Kovalik; A S Dion; A Langleben; G Boileau; G Boos; L Panasci
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.